
C2-Ai
C2-Ai provides globally unique Ai-backed systems that help hospitals to demonstrably reduce avoidable harm, mortality and variation.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
N/A | €0.0 Valuation: €0.0 | round | |
N/A | Grant | ||
Total Funding | 000k |
Related Content
C2-Ai, also known as Copeland Clinical Ai, is a company specializing in precision healthcare solutions. The company develops AI-driven applications designed to be used at the point of care, requiring no additional training for healthcare professionals. These applications provide real-time, individualized risk assessments and care recommendations, helping hospitals manage patients more effectively and optimize outcomes. C2-Ai's retrospective audit system leverages clinical coding data created upon patient discharge, enabling hospitals to reduce avoidable variations, mortality, and harm. The company aims to set the global gold standard for improving healthcare quality, reducing harm, and delivering cost savings to hospitals worldwide. C2-Ai operates in the healthcare market, primarily serving hospitals and healthcare providers. Its business model is based on a Software as a Service (SaaS) approach, generating revenue through subscription fees for its AI-driven solutions. The company's goal is to become an integral part of precision medicine, providing hospitals with the necessary AI systems for real-time and personalized patient care.
Keywords: AI-driven, healthcare, precision medicine, patient outcomes, risk assessment, cost savings, SaaS, clinical coding, hospitals, personalized care.